Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Disney is planning to flood its streaming service, Disney+, with user-generated AI slop. During the company’s recent earnings call, Disney CEO Bob Iger said that the streaming service is “in the midst ...

Since March of this year, it's been possible to generate images directly within ChatGPT. Following a period where it briefly wasn't available to free users, you now don't even pay for one of OpenAI's ...

We’ve all been there, sitting down to plan a lesson and finding nothing but an empty screen. The cursor blinks, the clock ticks, and suddenly that spark you were counting on feels completely out of ...

Our research contributes to debates about the role of Universal Grammar constraints and crosslinguistic influence in sequential bilingual acquisition and use. We investigate experimentally how adult ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...

You can generate AI videos using Google VEO3 in three ways: via the Gemini app/website (with a Pro or Advanced subscription), through Google Cloud’s Vertex AI with $300 in free credits for 90 days, or ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...